Current Status
Not Enrolled
Price
$149
Get Started

Course

New Hampshire APRN Bundle

Pharmacology Contact Hours Awarded: 30

Start Course
Now

Course Overview

New Hampshire APRN Bundle

In this course we will cover a variety of nursing topics pertinent in the state of New Hampshire, which are listed in the course outline below. This course is appropriate for APRNs and RNs. Upon completion of this single module you will receive a certificate for 30 pharmacology contact hours.

Course Authors

  1. Cathleen Adams CNO, RN CENP
  2. Amy White, CNO, RN
  3. Maureen Sullivan-Tevault MS, BSN, RN, CEN, CDE
  4. Sarah Schulze MSN, NP
  5. Amanda Marten MSN, FNP-C
  6. Edith Fomuso MSN, CCM, RN
  7. Sadia A. MPH, MSN, WHNP-BC
  8. Abbie Schmitt MSN, RN
  9. Charmaine Robinson MSN-Ed, BSN, RN
  10. R.E. Hengsterman MSN, RN, MA

Course Outline

  1. Controlled Substances: A comprehensive review
  2. Tirzepatide for Type 2 Diabetes and Weight Management
  3. Semaglutide and Type 2 Diabetes
  4. Medication Assisted Treatment
  5. Hypertensive Agents
  6. Migraine Management
  7. Asthma Treatment and Monitoring
  8. SSRI Use in Major Depressive Disorder
  9. Anticoagulant Therapy
  10. SNRIs for Depression
  11. Corticosteroid Therapy
  12. Anti-arrhythmics
  13. Antibiotic Use for UTI
  14. Oral STI Medications

Accreditation Statement

Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

In this course, we will discuss APRN courses pertinent to renewal in New Hampshire. It will take the average learner 1800 minutes to complete and awards 30 contact hours of continuing education.

Course Outcomes

After completing this course, the learner will rate a 4 out of 5 on the Likert Scale for their ability to:

  1. Describe commonly prescribed opioids for pain management and understand their side effects and indications of use.
  2. Understand the drug classification of tirzepatide
  3. Describe the action of non-insulin injectable diabetes medication semaglutide.
  4. Discuss the prevalence of various substance-related problems among United States citizens.  
  5. Differentiate between the classes of antihypertensives and their mechanism of action. 
  6. Demonstrate understanding of the neurobiological and pathophysiological mechanisms underlying migraines.  
  7. Describe common side effects, including severe possible side effects, of medications used to manage asthma
  8. Describe common side effects, including severe possible side effects, of SSRIs
  9. Identify potential anticoagulants and differentiate between the classes of anticoagulants and their mechanism of action.
  10. Identify the types and uses of Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs).
  11. Describe the effect that corticosteroids have on the immune system.
  12. Discuss the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs, including drug absorption, distribution, metabolism, and excretion.
  13. Differentiate between uncomplicated and complicated UTI and summarize key considerations when prescribing antibiotics for UTI.
  14. Discuss the clinical criteria for prescribing oral STI medications.

Target Audience

  • Registered Nurses (RN)
  • Advanced Practice Registered Nurses (APRN)

Requirement for Completion

  1. Enrollment in the course by the learner
  2. Read and learn all course materials
  3. Complete the course evaluation
  4. Attest and testify learning of the course materials

Accreditations + Approvals

  • American Nurses Credentialing Center (ANCC) (P0614)
  • California Board of Registered Nursing (CEP 17418)
  • Kentucky Board of Nursing (7-0090)
  • Louisiana State Board of Nursing (58)
  • New York State Department of Education (IC 208)
  • New York State Department of Education Child Abuse #80996
  • Florida Board of Nursing (50-23983)

Disclosure of Relevant Financial Relationships

Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.

Start Course
Now

Course created on: June 05, 2024

Course Expires on: June 05, 2027

Course Offering: #352